Literature DB >> 16413063

IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination.

Pratima Deshpande1, Irah L King, Benjamin M Segal.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system. IL-12p40 monokines play a critical role in the generation of EAE-inducing CD4+T cells. Here we show that IL-12 directly upregulates the expression of the adhesion molecule, P-selectin glycoprotein ligand (PSGL-1), on B10.PL MBP-TCR transgenic T cells during their initial encounter with antigen. Pre-incubation of IL-12-stimulated myelin-reactive CD4+T cells with a blocking antibody against PSGL-1 reduced the incidence and severity of EAE. We conclude that IL-12-driven PSGL-1 expression can facilitate the development of autoimmune demyelination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413063     DOI: 10.1016/j.jneuroim.2005.11.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation.

Authors:  Zhenya Ni; Bruce Walcheck
Journal:  Clin Immunol       Date:  2009-08-08       Impact factor: 3.969

Review 2.  Th17 cells in autoimmune demyelinating disease.

Authors:  Benjamin Matthew Segal
Journal:  Semin Immunopathol       Date:  2010-02-27       Impact factor: 9.623

3.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.

Authors:  Weici Zhang; Rahul Sharma; Shyr-Te Ju; Xiao-Song He; Yanyan Tao; Koichi Tsuneyama; Zhigang Tian; Zhe-Xiong Lian; Shu Man Fu; M Eric Gershwin
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

5.  Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy.

Authors:  Rhoanne C McPherson; Joanne E Konkel; Catriona T Prendergast; John P Thomson; Raffaele Ottaviano; Melanie D Leech; Oliver Kay; Stephanie E J Zandee; Claire H Sweenie; David C Wraith; Richard R Meehan; Amanda J Drake; Stephen M Anderton
Journal:  Elife       Date:  2014-12-29       Impact factor: 8.140

Review 6.  Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.

Authors:  Kristi M Anderson; Katherine E Olson; Katherine A Estes; Ken Flanagan; Howard E Gendelman; R Lee Mosley
Journal:  Transl Neurodegener       Date:  2014-11-13       Impact factor: 8.014

7.  Pathogenic CD8 T cells in multiple sclerosis and its experimental models.

Authors:  Eric S Huseby; Priya G Huseby; Shivanee Shah; Rebecca Smith; Brian D Stadinski
Journal:  Front Immunol       Date:  2012-03-29       Impact factor: 7.561

8.  IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

Authors:  Mark A Kroenke; Thaddeus J Carlson; Anuska V Andjelkovic; Benjamin M Segal
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

9.  An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.

Authors:  Joshua S Stoolman; Patrick C Duncker; Amanda K Huber; David A Giles; Jesse M Washnock-Schmid; Athena M Soulika; Benjamin M Segal
Journal:  J Neuroinflammation       Date:  2018-07-16       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.